We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. Show more
Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.6398 | -44.7412587413 | 1.43 | 1.555 | 0.7043 | 1498615 | 0.85077297 | CS |
4 | -0.5098 | -39.2153846154 | 1.3 | 1.7382 | 0.7043 | 645263 | 1.12721379 | CS |
12 | -2.0308 | -71.9886565048 | 2.821 | 3.09 | 0.7043 | 978740 | 1.76113419 | CS |
26 | -6.8298 | -89.6299212598 | 7.62 | 11.41 | 0.7043 | 650744 | 3.03052877 | CS |
52 | -2.8498 | -78.2912087912 | 3.64 | 11.41 | 0.7043 | 647663 | 4.48309608 | CS |
156 | -12.4598 | -94.0362264151 | 13.25 | 13.535 | 0.7043 | 358436 | 4.55108178 | CS |
260 | -14.2098 | -94.732 | 15 | 18.67 | 0.7043 | 255514 | 5.63352576 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions